This site is intended for health professionals only

Published on 4 February 2010

Share this story:

RELATED ARTICLES
Denosumab for menopausal and cancer-related bone loss
Patient knowledge of colorectal cancer therapy side-effects
Understanding compassionate-use programmes
ECCMID: Developments in invasive fungal disease
ECCO President’s preview of the Congress

GSK launches new research unit

teaser

↓Article continues below this sponsored advert↓
↑Advertisement↑

GSK today announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases.






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Risankizumab cleared by EMA for treatment of active psoriatic arthritis
Adjuvant alectinib found to be effective in early-stage ALK-positive non-small cell lung cancer
Contact tracing apps unlikely to reduce the spread of COVID-19
NICE unable to recommend pemetrexed
Patient safety and new technology challenges
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x